PharmaTutor Magazine | Volume 3, Issue 6 for June 15
Taro Pharmaceutical Industries has posted strong net profit growth of 70 per cent during the fourth quarter ended March 2015 to US$ 153 million from $90 million in the similar period of last year. Its net sales up by 30.5 per cent to $244 million from $187 million. With smart improvement in earnings, EPS worked out to $3.56 as against $2.10 in the last period. Its R&D expenses raised to $23.9 million from $13.1 million and selling, marketing, general and administrative expenses declined by 16.5 per cent to $22.2 million from $26.6 million.
OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", OMICS Group publishes 500 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS Group also organizes 300 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.
.png)
